United Health Products (UEEC) Net Equity Issued and Repurchased (2010 - 2024)
United Health Products (UEEC) posted quarterly Net Equity Issued and Repurchased of -$755841.0 for Q4 2024, up 56.13% year-over-year from -$484119.3 in Q1 2024, and down 482.07% quarter-over-quarter from $197826.0 in Q3 2024.
United Health Products (UEEC) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
United Health Products (UEEC) has reported Net Equity Issued and Repurchased for 11 consecutive years, with -$755841.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Net Equity Issued and Repurchased rose 56.13% year-over-year to -$755841.0; the TTM figure through Dec 2024 stood at $66000.0 (changed N/A YoY), while the FY2024 annual figure was $66000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased declined to -$755841.0 in Q4 2024 per UEEC's latest filing, from $197826.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $826696.0 in Q1 2020 and bottomed at -$1.7 million in Q4 2023.
- Historically, Net Equity Issued and Repurchased has averaged $108963.8 across 5 years, with a median of $197826.0 in 2024.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 5628.62% in 2023 and fell as far as 2041.42% in 2023.
- United Health Products' Net Equity Issued and Repurchased stood at $25000.0 in 2020, then soared by 115.21% to $53802.0 in 2021, then jumped by 64.94% to $88739.0 in 2022, then sank by 2041.42% to -$1.7 million in 2023, then surged by 56.13% to -$755841.0 in 2024.
- Business Quant data shows UEEC's Net Equity Issued and Repurchased at -$755841.0 in Q4 2024, $197826.0 in Q3 2024, and $228590.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 29.31 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | United Health Products | 9.79 Mn | 9.77 Mn | - | 44,946.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -755,841.00 |
| Dec 31, 2024 | -755,841.00 |
| Sep 30, 2024 | 197,826.00 |
| Sep 30, 2024 | 197,826.00 |
| Jun 30, 2024 | 228,590.00 |
| Jun 30, 2024 | 228,590.00 |
| Mar 31, 2024 | 395,425.00 |
| Mar 31, 2024 | 395,425.00 |
| Dec 31, 2023 | -1.72 Mn |
| Dec 31, 2023 | -1.72 Mn |
| Sep 30, 2023 | 564,613.00 |
| Sep 30, 2023 | 564,613.00 |
| Jun 30, 2023 | 579,325.00 |
| Jun 30, 2023 | 579,325.00 |
| Mar 31, 2023 | 578,855.00 |
| Mar 31, 2023 | 578,855.00 |
| Dec 31, 2022 | 88,739.00 |
| Dec 31, 2022 | 88,739.00 |
| Sep 30, 2022 | 9,856.00 |
| Sep 30, 2022 | 9,856.00 |